抗IFN-γ抗体(Anti-IFN-γ, Goat-Poly antibody)

掲載日情報:2021/01/28 現在Webページ番号:31204

IFN-γに対する抗体(Anti-IFN-γ, Goat-Poly )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年12月13日 13時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-IFN-γ, Goat-Poly
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • メーカーサイト
  • お問い合わせ
説明文
マッチドペア:Equine IFN-γ サンドイッチELISAの補足用抗体として利用可能,検出用抗体として#BAF1586,スタンダードとして#1586-HG-025を用いる。
別名:IFG
Genbank No: 3458
Protein Accession No: P42160
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 Equine 免疫動物 Goat クラス IgG 標識 Unlabeled
交差性 Equine 適用 ELISA,IC,Neutralising,Western Blot
クロナリティ Polyclonal フォーマット 性状 Antigen Affinity Purified 吸収処理
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
抗幹細胞マーカー抗体/抗造血幹細胞マーカー抗体(R&D Systems社)
Helper T Cells Marker Antibodies
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド
Anti-Equine IFN-gamma Affinity Purified Polyclonal Ab
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • メーカーサイト
  • お問い合わせ
説明文
※受注発注品。形状:溶液または凍結乾燥
別名:IFG
Genbank No: 3458
Protein Accession No: P42160
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 免疫動物 Goat クラス IgG 標識 Unlabeled
交差性 Equine 適用 ELISA,IC,Neutralising,Western Blot
クロナリティ Polyclonal フォーマット 性状 Antigen Affinity Purified 吸収処理
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
抗幹細胞マーカー抗体/抗造血幹細胞マーカー抗体(R&D Systems社)
Helper T Cells Marker Antibodies
使いっきり抗体
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2025年12月13日 13時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-IFN-γ, Goat-Poly

文献数: 0

説明文 マッチドペア:Equine IFN-γ サンドイッチELISAの補足用抗体として利用可能,検出用抗体として#BAF1586,スタンダードとして#1586-HG-025を用いる。
別名:IFG
Genbank No: 3458
Protein Accession No: P42160
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 Equine 免疫動物 Goat
交差性 Equine 適用 ELISA,IC,Neutralising,Western Blot
標識 Unlabeled 性状 Antigen Affinity Purified
吸収処理 クラス IgG
クロナリティ Polyclonal フォーマット
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
抗幹細胞マーカー抗体/抗造血幹細胞マーカー抗体(R&D Systems社)
Helper T Cells Marker Antibodies
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

Anti-Equine IFN-gamma Affinity Purified Polyclonal Ab

文献数: 0

説明文 ※受注発注品。形状:溶液または凍結乾燥
別名:IFG
Genbank No: 3458
Protein Accession No: P42160
別包装品 別包装品あり
法規制等
保存条件 法規備考
抗原種 免疫動物 Goat
交差性 Equine 適用 ELISA,IC,Neutralising,Western Blot
標識 Unlabeled 性状 Antigen Affinity Purified
吸収処理 クラス IgG
クロナリティ Polyclonal フォーマット
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
抗幹細胞マーカー抗体/抗造血幹細胞マーカー抗体(R&D Systems社)
Helper T Cells Marker Antibodies
使いっきり抗体
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityEquine
LabelUnconjugated
ImmunogenE. coli-derived recombinant equine IFN-gamma Ala25-Gln166Accession # P42160
SourcePolyclonal Goat IgG
PurificationAntigen Affinity-purified
SpecificityDetects equine IFN‑ gamma in ELISAs and Western blots. In sandwich immunoassays, approximately 20% cross‑reactivity with recombinant canine IFN‑ gamma is observed, less than 6% cross‑reactivity with recombinant bovine IFN‑ gamma and recombinant feline IFN‑ gamma is observed, and less than 0.2% cross‑reactivity with recombinant human IFN‑ gamma, recombinant mouse IFN‑ gamma, recombinant rat IFN‑ gamma, recombinant porcine IFN‑ gamma, recombinant rhesus macaque IFN‑ gamma, and recombinant cotton rat IFN‑ gamma is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Western Blot0.1 µg/mLRecombinant Equine IFN-gamma (Catalog # 1586-HG)
Immunocytochemistry5-15 µg/mLSee below
Equine IFN-gamma Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)0.2-0.8 µg/mL Equine IFN‑ gamma Antibody (Catalog #AF1586 )
ELISA Detection (Matched Antibody Pair)0.1-0.4 µg/mL Equine IFN‑ gamma Biotinylated Antibody (Catalog #BAF1586 )
ELISA Standard  Recombinant Equine IFN-gamma Protein (Catalog #1586-HG )
NeutralizationMeasured by its ability to neutralize IFN‑ gamma inhibition of EMCV-induced cytopathy in the L‑929 mouse fibroblast cell line. Vogel, S. and M. Hogan (1995) in Current Protocols in Immunology. Ciocio, R. (ed); John Wiley & Sons, Inc. p. 6. 9. 1. The Neutralization Dose (ND50) is typically 0.25-1.25 µg/mL in the presence of 20 ng/mL Recombinant Equine IFN‑ gamma.
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.

目次に戻る

Data Examples

Neutralization Neutralization IFN-gamma Antibody [Unconjugated]
click image to view larger
IFN‑ gamma  Inhibition of EMCV-induced Cytopathy and Neutralization by Equine IFN‑ gamma Antibody.
Recombinant Equine IFN‑ gamma (Catalog # 1586‑HG) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the L‑929 mouse fibroblast cell line in a dose‑dependent manner (orange line), as measured by Resazurin (Catalog # AR002). Inhibition of EMCV activity elicited by Recombinant Equine IFN‑ gamma (20 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Equine IFN‑ gamma Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1586). The ND50 is typically 0.25-1.25 µg/mL.
Immunocytochemistry Immunocytochemistry IFN-gamma Antibody [Unconjugated]
click image to view larger
IFN‑ gamma in Equine PBMCs.IFN‑ gamma was detected in immersion fixed equine peripheral blood mononuclear cells (PBMCs) treated with Calcium Ionomycin and PMA using Goat Anti-Equine IFN‑ gamma Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1586) at 15 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
ReconstitutionReconstitute at 0.2 mg/mL in sterile PBS.Reconstitution Buffer Available
ShippingThe product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IFN-gammaInterferon-gamma (IFN-gamma ), also known as type II or immune interferon, exerts a wide range of immunoregulatory activities and is considered to be the prototype proinflammatory cytokine (1, 2). Mature equine IFN-gamma exists as a noncovalently linked homodimer of 20‑25 kDa variably glycosylated subunits (3, 4). It shares 73%‑82% amino acid sequence identity with bovine, canine, feline, and porcine IFN-gamma and 42%‑64% with cotton rat, human, mouse, rat, and rhesus IFN-gamma. IFN-gamma dimers bind to IFN-gamma RI (alpha subunits) which then interact with IFN-gamma RII (beta subunits) to form the functional receptor complex of two alpha and two beta subunits. Inclusion of IFN-gamma RII increases the binding affinity for ligand and the efficiency of signal transduction (5, 6). IFN-gamma is produced by a variety of immune cells under inflammatory conditions, notably by T cells and NK cells (7). It plays a key role in host defense by promoting the development and activation of Th1 cells, chemoattraction and activation of monocytes and macrophages, upregulation of antigen presentation molecules, and immunoglobulin class switching in B cells. It also exhibits antiviral, antiproliferative, and apoptotic effects (7, 8). In addition, IFN-gamma functions as an anti-inflammatory mediator by promoting the development of regulatory T cells and inhibiting Th17 cell differentiation (9, 10). The pleiotropic effects of IFN-gamma contribute to the development of multiple aspects of atherosclerosis (8).

目次に戻る

References

Billiau, A. and P. Matthys (2009) Cytokine Growth Factor Rev. 20:97.
Pestka, S. et al. (2004) Immunol. Rev. 202:8.
Grunig, G. et al. (1994) Immunogenetics 39:448.
Curran, J.A. et al. (1994) DNA Seq. 4:405.
Marsters, S.A. et al. (1995) Proc. Natl. Acad. Sci. 92:5401.
Krause, C.D. et al. (2000) J. Biol. Chem. 275:22995.
Schroder, K. et al. (2004) J. Leukoc. Biol. 75:163.
McLaren, J.E. and D.P. Ramji (2009) Cytokine Growth Factor Rev. 20:125.
Muhl, H. and J. Pfeilschifter (2003) Int. Immunopharmacol. 3:1247.
Kelchtermans, H. et al. (2008) Trends Immunol. 29:479.
Long Name:Interferon gamma
Entrez Gene IDs:3458 (Human); 15978 (Mouse); 25712 (Rat); 396991 (Porcine); 281237 (Bovine); 403801 (Canine); 493965 (Feline)
Alternate Names:IFG; IFI; IFNG; IFNgamma; IFN-gamma; Immune interferon; interferon gamma; interferon, gamma

目次に戻る

Related Research Areas

Conventional/Classical Dendritic Cells
Cytokines and Receptors in Allergy and Asthma
Cytokines and Receptors in Angiogenesis
Cytokines and Receptors in Tfh Cell Differentiation and Function
gamma delta T Cells
Group 1 ILCs
IL-10/Interferon Family
Infectious Diseases
Inflammatory Mediators
Isolation, Culture, and Identification of Natural Killer Cells
Macrophage Activation Markers
Molecules Secreted by VSMC
Multiple Sclerosis and Myelin Related Molecules
Myeloid-derived Suppressor Cells (MDSC)
Natural Killer T (NKT) Cells
NCR+ILC3
NCR-ILC3
Neuroinflammation
Regulatory T Cells (Tregs)
T Cell Cytokine Signaling
Th1 Cells


Neutralization
IFN‑ gamma  Inhibition of EMCV-induced Cytopathy and Neutralization by Equine IFN‑ gamma Antibody.
Recombinant Equine IFN‑ gamma (Catalog # 1586‑HG) reduces the Encephalomyocarditis Virus (EMCV)-induced cytopathy in the L‑929 mouse fibroblast cell line in a dose‑dependent manner (orange line), as measured by Resazurin (Catalog # AR002). Inhibition of EMCV activity elicited by Recombinant Equine IFN‑ gamma (20 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Equine IFN‑ gamma Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1586). The ND50 is typically 0.25-1.25 µg/mL.
Immunocytochemistry
IFN‑ gamma in Equine PBMCs.
IFN‑ gamma was detected in immersion fixed equine peripheral blood mononuclear cells (PBMCs) treated with Calcium Ionomycin and PMA using Goat Anti-Equine IFN‑ gamma Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1586) at 15 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.


目次に戻る

Related Product & Information

Long NameInterferon gamma
Entrez Gene IDs3458 (Human); 15978 (Mouse); 25712 (Rat); 396991 (Porcine); 281237 (Bovine); 403801 (Canine); 493965 (Feline)
BackgroundIFN-gamma
background_contentBackground:
IFN-gamma
Interferon-gamma (IFN-gamma ), also known as type II or immune interferon, exerts a wide range of immunoregulatory activities and is considered to be the prototype proinflammatory cytokine (1, 2). Mature equine IFN-gamma exists as a noncovalently linked homodimer of 20‑25 kDa variably glycosylated subunits (3, 4). It shares 73%‑82% amino acid sequence identity with bovine, canine, feline, and porcine IFN-gamma and 42%‑64% with cotton rat, human, mouse, rat, and rhesus IFN-gamma. IFN-gamma dimers bind to IFN-gamma RI (alpha subunits) which then interact with IFN-gamma RII (beta subunits) to form the functional receptor complex of two alpha and two beta subunits. Inclusion of IFN-gamma RII increases the binding affinity for ligand and the efficiency of signal transduction (5, 6). IFN-gamma is produced by a variety of immune cells under inflammatory conditions, notably by T cells and NK cells (7). It plays a key role in host defense by promoting the development and activation of Th1 cells, chemoattraction and activation of monocytes and macrophages, upregulation of antigen presentation molecules, and immunoglobulin class switching in B cells. It also exhibits antiviral, antiproliferative, and apoptotic effects (7, 8). In addition, IFN-gamma functions as an anti-inflammatory mediator by promoting the development of regulatory T cells and inhibiting Th17 cell differentiation (9, 10). The pleiotropic effects of IFN-gamma contribute to the development of multiple aspects of atherosclerosis (8).


目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。